Exhibit 99.1

MB SOFTWARE CORPORATION ANNOUNCES MERGER

ARLINGTON, Texas, Aug 20, 2004 (BUSINESS WIRE) -- MB Software Corporation
[MBSB], announced today that the Company has consummated the acquisition of
Wound Care Innovations, LLC in exchange for an aggregate of 8,257,303 shares of
the Company's common stock.

Wound Care Innovations, LLC is the worldwide distributor of CellerateRx(TM)
products, advanced collagen-based wound care products featuring a patented
molecular form of collagen. These FDA approved products are marketed and
distributed by Wound Care Innovations exclusively in the domestic medical,
retail, government and first aid human use wound care markets, as well as most
international territories.

Mr. Scott Haire, the Company's President and CEO, states, "We are very excited
about the capabilities of these products, the patented science behind them, and
the strong business case they provide to healthcare providers currently facing
deep financial losses on wound-related cases. Collagen's use in wound care is
not new, but the proprietary molecular form found in CellerateRx brings
collagen's benefit to the wound site faster, is completely biocompatible, and
its performance has already garnered us customers from among the best known
names in hospitals, long term care, home care, and wound care centers.

"We believe that the acquisition of Wound Care Innovations, together with the
Company's implementation of the recently acquired Veriscrip(TM) technologies
furthers the Company's near and long term objectives of capitalizing on emerging
trends in the healthcare market sector, by providing solutions that exceed our
customers expectations in the areas of product performance and reduced costs."

Wound Care Innovations also holds an option to purchase the patent upon which
Wound Care Innovations' products are based.


About MB Software Corporation:

MB Software Corporation [MBSB] with its corporate headquarters based in
Arlington, Texas, offers products and services to the healthcare industry that
are designed to arrest exponentially increasing costs currently experienced by
the healthcare professional and regulatory agencies. MB Software Corporation
plans continued aggressive marketing of its products throughout the United
States, while pursuing timely avenues of financing that permit expansion of
future marketing endeavors, and in support of appropriate operational
requirements that allow for building requisite inventory levels to accommodate
the Company's increasing customer base.

This document may contain forward-looking statements concerning the Company's
operations, current and future performance and financial condition. These items
involve risks and uncertainties such as product demand, market and customer
acceptance, the





effect of economic conditions, competition, pricing, the ability
to consummate and integrate acquisitions, and other risks and uncertainties
detailed in the Company's SEC filings. The Company undertakes not obligation to
revise any of these statements to reflect the future circumstances or the
occurrence of unanticipated events.